The risk of recurrence for women after early stage breast cancer treatment. Plus, the protective benefits of endocrine and HER-2 therapies; what tests and imaging should be done for surveillance; and how to manage the anxiety of possible recurrence. From Antonio Wolff, M.D., medical oncologist at the Johns Hopkins Sydney Kimmel Comprehensive Cancer Center in Baltimore, MD.
Link to this comment:
All Comments (0)